# Metformin for Premature Infants With Bronchopulmonary Dysplasia

> **NCT07120971** · EARLY_PHASE1 · RECRUITING · sponsor: **Medical College of Wisconsin** · enrollment: 40 (estimated)

## Conditions studied

- Bronchopulmonary Dysplasia (BPD)

## Interventions

- **DRUG:** Metformin (open-label)
- **DRUG:** Metformin (open-label)
- **DRUG:** Metformin (open-label)
- **DRUG:** Metformin (open-label)
- **DRUG:** Metformin (open-label)
- **DRUG:** Metformin (open-label)
- **DRUG:** Metformin (open-label)
- **DRUG:** Metformin (open-label)
- **DRUG:** Metformin (open-label)

## Key facts

- **NCT ID:** NCT07120971
- **Lead sponsor:** Medical College of Wisconsin
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-12-19
- **Primary completion:** 2028-09-01
- **Final completion:** 2030-09-01
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2026-01-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07120971

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07120971, "Metformin for Premature Infants With Bronchopulmonary Dysplasia". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT07120971. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*